MKS Instruments, Inc. (NASDAQ:MKSI) Expected to Announce Quarterly Sales of $487.37 Million

Wall Street analysts expect that MKS Instruments, Inc. (NASDAQ:MKSI) will post sales of $487.37 million for the current quarter, according to Zacks Investment Research. Four analysts have provided estimates for MKS Instruments’ earnings, with the highest sales estimate coming in at $490.07 million and the lowest estimate coming in at $482.10 million. MKS Instruments posted sales of $573.14 million during the same quarter last year, which would indicate a negative year-over-year growth rate of 15%. The company is expected to issue its next earnings report after the market closes on Tuesday, July 30th.

According to Zacks, analysts expect that MKS Instruments will report full-year sales of $2.02 billion for the current fiscal year, with estimates ranging from $1.94 billion to $2.08 billion. For the next year, analysts anticipate that the business will post sales of $2.31 billion, with estimates ranging from $2.24 billion to $2.43 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that follow MKS Instruments.

MKS Instruments (NASDAQ:MKSI) last posted its earnings results on Monday, April 29th. The scientific and technical instruments company reported $1.12 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.07 by $0.05. The company had revenue of $463.60 million during the quarter, compared to analyst estimates of $460.64 million. MKS Instruments had a return on equity of 20.38% and a net margin of 15.13%. The business’s revenue was down 16.4% compared to the same quarter last year. During the same period in the prior year, the company earned $2.07 earnings per share.



Several equities analysts have recently commented on MKSI shares. Deutsche Bank lowered J B Hunt Transport Services from a “buy” rating to a “sell” rating and set a $98.51 target price for the company. in a report on Wednesday, April 17th. Zacks Investment Research lowered Wix.Com from a “hold” rating to a “sell” rating in a report on Monday, April 8th. Stifel Nicolaus set a $8.00 target price on FreightCar America and gave the company a “hold” rating in a report on Tuesday, April 2nd. Cowen reaffirmed a “buy” rating and set a $220.00 target price on shares of Vertex Pharmaceuticals in a report on Tuesday, April 30th. Finally, Benchmark upped their target price on MKS Instruments from $98.00 to $111.00 and gave the company a “buy” rating in a report on Friday, March 29th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $113.44.

Shares of NASDAQ:MKSI traded down $1.17 during trading on Friday, hitting $79.20. 263,973 shares of the company traded hands, compared to its average volume of 484,357. The company has a market capitalization of $4.37 billion, a PE ratio of 10.11, a price-to-earnings-growth ratio of 1.27 and a beta of 1.43. The stock has a fifty day simple moving average of $75.97. MKS Instruments has a one year low of $56.37 and a one year high of $103.86. The company has a quick ratio of 2.98, a current ratio of 4.59 and a debt-to-equity ratio of 0.51.

In related news, Director Elizabeth Mora sold 400 shares of the stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $71.93, for a total value of $28,772.00. Following the completion of the transaction, the director now directly owns 16,618 shares of the company’s stock, valued at approximately $1,195,332.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Gerard G. Colella sold 5,000 shares of the stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $75.82, for a total value of $379,100.00. The disclosure for this sale can be found here. Insiders sold a total of 5,656 shares of company stock valued at $429,852 over the last three months. Corporate insiders own 1.24% of the company’s stock.

A number of hedge funds have recently modified their holdings of MKSI. Valeo Financial Advisors LLC bought a new position in MKS Instruments in the 1st quarter worth approximately $39,000. AlphaOne Investment Services LLC bought a new position in MKS Instruments during the 1st quarter valued at $45,000. Quadrant Capital Group LLC boosted its stake in MKS Instruments by 602.1% during the 1st quarter. Quadrant Capital Group LLC now owns 681 shares of the scientific and technical instruments company’s stock valued at $62,000 after purchasing an additional 584 shares in the last quarter. Icon Wealth Partners LLC bought a new position in MKS Instruments during the 1st quarter valued at $69,000. Finally, Penserra Capital Management LLC boosted its stake in MKS Instruments by 72.6% during the 1st quarter. Penserra Capital Management LLC now owns 1,160 shares of the scientific and technical instruments company’s stock valued at $107,000 after purchasing an additional 488 shares in the last quarter. 94.95% of the stock is owned by institutional investors and hedge funds.

MKS Instruments Company Profile

MKS Instruments, Inc provides instruments, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes worldwide. It operates through two segments, Vacuum and Analysis, and Light and Motion. The Vacuum and Analysis segment offers analytical and control solutions, including gas analyzers, automation control products, I/O modules, automation software, and precision machined components and electromechanical assemblies; direct and indirect pressure measurement and integrated process solutions; and materials delivery solutions comprising flow and valve technologies, as well as integrated pressure measurement and control subsystems to provide customers with control capabilities that are optimized for a given application.

Read More: Net Margin – Understanding the Different Kinds of Profit

Get a free copy of the Zacks research report on MKS Instruments (MKSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MKS Instruments (NASDAQ:MKSI)

Receive News & Ratings for MKS Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments and related companies with MarketBeat.com's FREE daily email newsletter.